A summary of microbiome research related to depression is provided in Table 5
While neither GIP nor glucagon seem to exert sufficient individual effects to justify their clinical use in the treatment of type 2 diabetes and obesity, the combination of these hormones with GLP-1 may represent a new treatment strategy in the near future
Baker, PharmD, FCCP, FACC, FHFSA, Clinical Professor, University of Connecticut School of Pharmacy, Storrs, CT 0009-0000-25-064-L01-P (0.1 CEU or 1 contact hour) (Application-based) 11:25-12:25 p.m
Weight loss interventions in primary care settings
As collagen production continues to rise, the skin becomes firmer, smoother, and more youthful-looking
As Kennedy himself acknowledged during the February 2026 announcement, the Category 2 designations effectively created and accelerated the very gray market they were designed to prevent